MarketFoolery

  Columnist Morgan Housel shares his thoughts on the Federal Reserve’s upcoming meeting, what a rise in interest rates means for investors, and why bond investors should be concerned.

Apple rises on an upbeat sales forecast for new iPhones.  Is Goldman Sachs correct in thinking oil could hit $20 a barrel?  Plus, we analyze McDonald’s move (finally!) to all-day breakfast and Amazon’s test of 1-hour alcohol delivery.

Lululemon Athletica falls after lowering guidance. We analyze the highlights from Apple’s product launch. Plus, we discuss Ambarella’s recent plunge and how long FireEye’s unprofitability should worry investors.

United Continental’s CEO suddenly resigns, but Wall Street appears unfazed.  Dave & Buster’s hits an all-time high, putting the stock in Shake Shack territory.  With the NFL season about to begin, we analyze the rising (and seemingly unstoppable) business of fantasy football.  Plus, we discuss the prospects for our fantasy team, televised darts, and the unheralded sport of sheep herding. 

We dip into the Fool Mailbag to analyze the best ways to diversify your portfolio, when to STOP researching a company, and how to decide when to add to a position.

After a rough month for investors Chris Hill reflects on the audacity of individual stock investing, his recent trip to northern California, what he learned inside Pixar Animation, and the poetry of Rudyard Kipling.  

Tim Hanson discusses everything from ETF-based investments in Brazil and China, to specific global investments like Tencent Holdings.  He also shares why U.S. investors should read non-U.S. news every day.

There are opportunities to be had in the biotechnology and pharmaceutical industries, but some investors shy away because of the “Sleep Factor”.  Industry Focus host Kristine Harjes analyzes the drug approval process and why every investor should take a close look at this industry.  She also shares two drugmaker stocks she likes right now, and introduces the term “bleeding event” to the conversation.

Chris Hill discusses key resources for investors, why he’s a fan of charts, and the investing lessons he recently learned from filmmaker Robert Rodriguez.

Ron Gross kicks off “Strategy Week” with a primer on value investing, including key metrics to look for and why management is a key factor in “deep value” investing.